![Horst Domdey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Horst Domdey
Amministratore Delegato presso
BioM AG Munich BioTech Development
Profilo
Horst Domdey was the founder of MediGene AG, holding the title of Chairman-Supervisory Board from 2013 to 2019.
Dr. Domdey is also the founder of BIO Deutschland, Switch Biotech AG, Council of European Bioregions.
Current jobs include Chairman, President & Chief Executive Officer at BioM.
Biotech Cluster Development GmbH since 2014, Managing Director at BioM AG Munich BioTech Development since 2010, Director at HP Health Solutions Germany GmbH, Scientific Director at Baygene since 2003, Scientific Director at Genome Research Network since 2003, and Member-Supervisory Board at Max-Delbrück-Centrum für Molekulare Medizin (MDC).
Former jobs include Independent Non-Executive Director at Vivesto AB from 2011 to 2016 and Professor at Ludwig-Maximilians-Universität München.
Education includes a doctorate from Ludwig-Maximilians-Universität München.
Posizioni attive di Horst Domdey
| Società | Posizione | Inizio |
|---|---|---|
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Amministratore Delegato | 01/04/1998 |
BioM Biotech Cluster Development GmbH
 BioM Biotech Cluster Development GmbH Medical DistributorsDistribution Services BioM AG is a regional technology transfer and venture capital services company created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition. The firm provides business support services to Munich-based biotechnology companies, focusing on startups. Through BioM Biotech Cluster Development GmbH, established in 2006, BioM coordinates the Munich Biotech Cluster, with the objective of turning it into a leading biotechnology center in Europe. They seek to foster an active cooperation between Bavarian research institutions and corporations. BioM actively invests seed capital in biotechnology startups in the Munich area, and manages a venture capital investment fund invested in high-growth early-stage businesses. | Amministratore Delegato | 01/01/1997 |
Baygene | Direttore Tecnico/Scientifico/R&S | 01/01/2003 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical research institute | Direttore/Membro del Consiglio | - |
Genome Research Network | Direttore Tecnico/Scientifico/R&S | 01/01/2003 |
HP Health Solutions Germany GmbH
 HP Health Solutions Germany GmbH Miscellaneous Commercial ServicesCommercial Services Develops instruments for molecular pathogen detection | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Horst Domdey
| Società | Posizione | Fine |
|---|---|---|
| VIVESTO AB | Direttore/Membro del Consiglio | 21/11/2016 |
Council of European Bioregions
 Council of European Bioregions Miscellaneous Commercial ServicesCommercial Services Operates membership based biotechnology organization | Fondatore | - |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services Operates as business association for biotechnology industry | Fondatore | - |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Horst Domdey
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
38
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
BioM Biotech Cluster Development GmbH
BioM Biotech Cluster Development GmbH Medical DistributorsDistribution Services BioM AG is a regional technology transfer and venture capital services company created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition. The firm provides business support services to Munich-based biotechnology companies, focusing on startups. Through BioM Biotech Cluster Development GmbH, established in 2006, BioM coordinates the Munich Biotech Cluster, with the objective of turning it into a leading biotechnology center in Europe. They seek to foster an active cooperation between Bavarian research institutions and corporations. BioM actively invests seed capital in biotechnology startups in the Munich area, and manages a venture capital investment fund invested in high-growth early-stage businesses. | Distribution Services |
BioM AG Munich BioTech Development
BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Finance |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical research institute | Commercial Services |
BIO Deutschland
BIO Deutschland Miscellaneous Commercial ServicesCommercial Services Operates as business association for biotechnology industry | Commercial Services |
HP Health Solutions Germany GmbH
HP Health Solutions Germany GmbH Miscellaneous Commercial ServicesCommercial Services Develops instruments for molecular pathogen detection | Commercial Services |
Baygene | |
Switch Biotech AG | |
Council of European Bioregions
Council of European Bioregions Miscellaneous Commercial ServicesCommercial Services Operates membership based biotechnology organization | Commercial Services |
Genome Research Network |
